Stability_Shelf_Life_Predictor
Stability Shelf Life Predictor
Utility description: Stability Shelf Life Predictor
Stability Shelf Life Predictor — Shelf Life Prediction (Arrhenius Model) ℹ️ Utility estimates potential drug shelf life based on degradation kinetics: • Input: Accelerated testing results (e.g., 40°C/75% RH) • Model: Arrhenius equation to extrapolate reaction rate to storage conditions (25°C) • Output: Predicted time (years) to reach specification limit ⚠️ CRITICAL: Prediction is less reliable for complex processes (autocatalytic, phase transitions). Always confirm prediction with Real-Time Stability data! Usage: Stability_Shelf_Life_Predictor.exe → demo mode (console output) Stability_Shelf_Life_Predictor.exe input.csv output.json → evaluate your data Input format: BatchNumber,InitialAssayPercent,AcceleratedAssayPercent,AcceleratedTimeMonths,LowerSpecificationLimit,ActivationEnergyKJ Example: STAB-PRED-2026-001,100.0,98.5,6.0,90.0,83.14 — WHY IS THIS NEEDED? Shelf life determination is a key step in drug registration (ICH Q1A(R2)). • Real-time studies take years. Accelerated Testing allows rapid stability assessment. • Using kinetic models (Arrhenius equation) allows extrapolating high-temperature data to storage conditions. • Helps identify unstable formulations at early development stages. • Allows justification of preliminary shelf life for clinical batches. ⚠️ CRITICAL: • Model assumes degradation mechanism does not change with temperature. • Activation Energy (Ea) strongly affects the result. If unknown, average value ~83 kJ/mol (20 kcal/mol) is used. • Prediction is valid only in temperature range where no phase transitions (melting, glass transition) occur. • For moisture-sensitive drugs, more complex model accounting for sorption isotherms is required. Key features: • Automatic calculation of degradation rate constant. • Application of Arrhenius equation for temperature correction. • Assessment of compliance with target shelf life (e.g., 2 or 3 years). Critical parameters: • Predicted Shelf Life: >= Target (e.g., 2 years) • Degradation Kinetics: Zero/First Order assumption • Activation Energy: User defined or Default (83.14 kJ/mol) 💡 Usage tips: 1. Use data from at least two temperatures (e.g., 40°C and 50°C) for more accurate Ea calculation. 2. Check linearity of degradation over time (correlation coefficient R² > 0.9). 3. Account for analytical method error when determining specification limit. 4. For protein drugs, Arrhenius model is often inapplicable due to denaturation; use empirical rules. 5. Save all raw stability study data for regulatory audit. ⚠️ Note: This utility implements a simplified approach (Single Point Prediction). For full registration dossier, statistical analysis of all time points is required (e.g., least squares method for determining confidence intervals of shelf life).
input.csv
BatchNumber,InitialAssay%,AccelAssay%,AccelTimeMonths,LowerSpec%,Ea_kJ STAB-PRED-2026-001,100.0,98.5,6.0,90.0,83.14 STAB-PRED-2026-002,100.0,95.0,6.0,90.0,83.14 STAB-FAIL-2026-003,100.0,92.0,6.0,90.0,83.14
Utility description
Stability Shelf Life Predictor — Shelf Life Prediction (Arrhenius Model) ℹ️ Utility estimates potential drug shelf life based on degradation kinetics: • Input: Accelerated testing results (e.g., 40°C/75% RH) • Model: Arrhenius equation to extrapolate reaction rate to storage conditions (25°C) • Output: Predicted time (years) to reach specification limit ⚠️ CRITICAL: Prediction is less reliable for complex processes (autocatalytic, phase transitions). Always confirm prediction with Real-Time Stability data! Usage: Stability_Shelf_Life_Predictor.exe → demo mode (console output) Stability_Shelf_Life_Predictor.exe input.csv output.json → evaluate your data Input format: BatchNumber,InitialAssayPercent,AcceleratedAssayPercent,AcceleratedTimeMonths,LowerSpecificationLimit,ActivationEnergyKJ Example: STAB-PRED-2026-001,100.0,98.5,6.0,90.0,83.14 — WHY IS THIS NEEDED? Shelf life determination is a key step in drug registration (ICH Q1A(R2)). • Real-time studies take years. Accelerated Testing allows rapid stability assessment. • Using kinetic models (Arrhenius equation) allows extrapolating high-temperature data to storage conditions. • Helps identify unstable formulations at early development stages. • Allows justification of preliminary shelf life for clinical batches. ⚠️ CRITICAL: • Model assumes degradation mechanism does not change with temperature. • Activation Energy (Ea) strongly affects the result. If unknown, average value ~83 kJ/mol (20 kcal/mol) is used. • Prediction is valid only in temperature range where no phase transitions (melting, glass transition) occur. • For moisture-sensitive drugs, more complex model accounting for sorption isotherms is required. Key features: • Automatic calculation of degradation rate constant. • Application of Arrhenius equation for temperature correction. • Assessment of compliance with target shelf life (e.g., 2 or 3 years). Critical parameters: • Predicted Shelf Life: >= Target (e.g., 2 years) • Degradation Kinetics: Zero/First Order assumption • Activation Energy: User defined or Default (83.14 kJ/mol) 💡 Usage tips: 1. Use data from at least two temperatures (e.g., 40°C and 50°C) for more accurate Ea calculation. 2. Check linearity of degradation over time (correlation coefficient R² > 0.9). 3. Account for analytical method error when determining specification limit. 4. For protein drugs, Arrhenius model is often inapplicable due to denaturation; use empirical rules. 5. Save all raw stability study data for regulatory audit. ⚠️ Note: This utility implements a simplified approach (Single Point Prediction). For full registration dossier, statistical analysis of all time points is required (e.g., least squares method for determining confidence intervals of shelf life).
URS & FS — User Requirements and Functional Specification
This document describes the controlled interface, user requirements and functional behaviour of Stability_Shelf_Life_Predictor. The utility is intended for automated verification of laboratory, pharmacopoeial, analytical or manufacturing QC parameters using input.csv and producing a structured output.json result.
Domain limits and critical parameters
- • Real-time studies take years. Accelerated Testing allows rapid stability assessment.
- • Using kinetic models (Arrhenius equation) allows extrapolating high-temperature data to storage conditions.
- • Helps identify unstable formulations at early development stages.
- • Allows justification of preliminary shelf life for clinical batches.
- • Model assumes degradation mechanism does not change with temperature.
- • Activation Energy (Ea) strongly affects the result. If unknown, average value ~83 kJ/mol (20 kcal/mol) is used.
- • Prediction is valid only in temperature range where no phase transitions (melting, glass transition) occur.
- • For moisture-sensitive drugs, more complex model accounting for sorption isotherms is required.
- • Automatic calculation of degradation rate constant.
- • Application of Arrhenius equation for temperature correction.
- • Assessment of compliance with target shelf life (e.g., 2 or 3 years).
- • Predicted Shelf Life: >= Target (e.g., 2 years)
- • Degradation Kinetics: Zero/First Order assumption
- • Activation Energy: User defined or Default (83.14 kJ/mol)
- Shelf life determination is a key step in drug registration (ICH Q1A(R2)).
- 2. Check linearity of degradation over time (correlation coefficient R² > 0.9).
URS — User Requirements Specification
| ID | Requirement | Criticality | Acceptance criterion |
|---|---|---|---|
| URS-001 | The utility shall accept an input.csv file with exact headers defined in the data contract. | High | The file is processed without manual header editing. |
| URS-002 | The utility shall perform deterministic evaluation for Stability Shelf Life Predictor using input values, approved limits and domain rules. | High | Each row receives a PASS / WARNING / FAIL status. |
| URS-003 | The utility shall validate mandatory fields, data types, numeric ranges, units and domain plausibility. | High | Schema, format and conversion errors are explicitly reported. |
| URS-004 | The utility shall identify critical deviations for parameters stated in the method description and specification. | High | A critical deviation causes FAIL or a dedicated critical finding. |
| URS-005 | The utility shall generate output.json with machine-readable results, source values, warnings and failures. | High | JSON is suitable for LIMS/ELN/MES integration, QA/QC review and archival. |
| URS-006 | The result shall not depend on machine learning or undocumented heuristics. | Medium | All decisions are based on explicit rules, thresholds and input values. |
| URS-007 | The system shall preserve traceability between batch/sample, input data, applied rules and final status. | High | The output contains the batch/sample identifier and checked parameters. |
| URS-008 | The documentation shall support IQ/OQ/PQ preparation and inspection discussion. | Medium | URS, FS, CSV/JSON contract and test scenarios are supplied with the utility. |
| URS-009 | The utility shall support batch processing of multiple input.csv rows. | Medium | Each row is evaluated independently; errors in one row do not mask errors in others. |
| URS-010 | The utility shall support a simple operating model: demo mode and execution with input/output files. | Medium | The CLI scenario is reproducible in test and production environments. |
input.csv contract
| # | Field | Type | Sample | Purpose |
|---|---|---|---|---|
| 1 | BatchNumber | string | STAB-PRED-2026-001 | Batch or lot identifier used for traceability, review and deviation investigation. |
| 2 | InitialAssay% | decimal | 100.0 | Content / assay value; key specification conformance metric. |
| 3 | AccelAssay% | decimal | 98.5 | Content / assay value; key specification conformance metric. |
| 4 | AccelTimeMonths | decimal | 6.0 | Time-related process or analytical observation parameter. |
| 5 | LowerSpec% | decimal | 90.0 | Controlled input parameter used by deterministic QC rules and traceable result generation. |
| 6 | Ea_kJ | string / decimal | 83.14 | Controlled input parameter used by deterministic QC rules and traceable result generation. |
BatchNumber,InitialAssay%,AccelAssay%,AccelTimeMonths,LowerSpec%,Ea_kJ STAB-PRED-2026-001,100.0,98.5,6.0,90.0,83.14 STAB-PRED-2026-002,100.0,95.0,6.0,90.0,83.14 STAB-FAIL-2026-003,100.0,92.0,6.0,90.0,83.14
FS — Functional Specification
| ID | Function | Implementation |
|---|---|---|
| FS-001 | CSV import | Read input.csv in UTF-8/CSV-compatible format and validate the header and expected columns. |
| FS-002 | Schema validation | Check mandatory fields, column count, critical missing values and row structure. |
| FS-003 | Type conversion | Convert numeric, flag and text values; invalid formats are recorded as row-level errors. |
| FS-004 | Domain rule engine | Apply domain rules for Stability Shelf Life Predictor, including limits from the utility description and approved specification. |
| FS-005 | Status aggregation | Produce final status: FAIL for critical failure, WARNING for non-critical deviation, PASS for conformance. |
| FS-006 | JSON export | Write output.json with detailed checks, source values, warnings, failures and critical findings. |
| FS-007 | Audit support | Keep the result structure suitable for review, deviation investigation, calculation reproduction and IQ/OQ/PQ preparation. |
| FS-008 | Integration contract | Support the production scenario: LIMS/ELN/MES creates input.csv, the utility returns output.json, and the portal displays description and documentation. |
| FS-009 | Error handling | Report errors unambiguously and do not substitute missing values with calculated values unless the rule is explicitly defined. |
| FS-010 | Version control support | Document the utility version, input contract, executable checksum and rule application date. |
Example output.json
{
"utilityId": "stability-shelf-life-predictor",
"utilityName": "Stability_Shelf_Life_Predictor",
"overallStatus": "PASS|WARNING|FAIL",
"sourceFile": "input.csv",
"checks": [
{
"parameter": "BatchNumber",
"value": "STAB-PRED-2026-001",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "InitialAssay%",
"value": "100.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "AccelAssay%",
"value": "98.5",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "AccelTimeMonths",
"value": "6.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "LowerSpec%",
"value": "90.0",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
},
{
"parameter": "Ea_kJ",
"value": "83.14",
"status": "PASS|WARNING|FAIL",
"message": "Rule-based check result"
}
],
"criticalFindings": [],
"warnings": [],
"generatedFor": "QA/QC review and LIMS integration"
}
Traceability matrix
| URS | FS | OQ/PQ coverage |
|---|---|---|
| URS-001, URS-003 | FS-001, FS-002, FS-003 | OQ-001/OQ-002/OQ-003 |
| URS-002, URS-004 | FS-004, FS-005 | OQ-004/PQ-001 |
| URS-005, URS-007 | FS-006, FS-007 | OQ-005/PQ-002 |
| URS-008, URS-010 | FS-008, FS-010 | IQ-001/OQ-006 |
OQ/PQ test scenarios
| ID | Scenario | Expected result |
|---|---|---|
| OQ-001 | Valid sample row | PASS or acceptable WARNING according to the rules. |
| OQ-002 | Mandatory column missing | Schema error or FAIL. |
| OQ-003 | Non-numeric value in numeric field | Type-conversion error. |
| OQ-004 | Critical parameter outside limit | FAIL and critical finding. |
| OQ-005 | Multiple rows with different statuses | Independent row-level evaluation. |
| PQ-001 | User real batch/sample | Reviewed result with retained input/output files. |
QA/QC and change control
- Do not rename columns without updating the validator, documentation and test set.
- Retain
input.csv,output.json, executable version, documentation and checksum. - Before production use, perform IQ/OQ/PQ or equivalent CSV/CSA verification.
- Critical limits must be verified against the approved specification, local SOPs and registration dossier.
Included in packages
Biopharmaceuticals Extended QC Suite
Extended QC utility coverage for mAbs, biosimilars, proteins, insulins, vaccines, mRNA/LNP, HCP, sterile release, microbiology, water, cleanroom and stability workflows.
OpenDental & Dental Materials QC Suite
QC utility package for dental medicinal products, oral-care products and dental materials: anaesthetics, antiseptics, analgesic/anti-infective products, polymers/minerals, resins, bonding workflows, microbiology, stability and material QC.
OpenLumex QC Suite
A single Lumex package combining the former Lumex and Lumex2 sets: instrumental and general pharmaceutical QC, AAS/ICP, CE, HPLC, NIR/PAT, stability, dissolution, content uniformity, system suitability and statistical control.
Open